Atlas Trials

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Clinical trial NCT00646503 · COMPLETED

Trial details

NCT number
NCT00646503
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2008-03-01
Primary completion
2009-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.